Mark CPA - Aytu BioScience Secretary CFO
| AYTU Stock | USD 1.61 0.01 0.62% |
CFO
Mark CPA is Secretary CFO of Aytu BioScience
| Age | 55 |
| Address | Denver Corporate Center III, Denver, CO, United States, 80237 |
| Phone | (720) 437-6580 |
| Web | https://aytubio.com |
Aytu BioScience Management Efficiency
The company has return on total asset (ROA) of (0.0106) % which means that it has lost $0.0106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4724) %, meaning that it created substantial loss on money invested by shareholders. Aytu BioScience's management efficiency ratios could be used to measure how well Aytu BioScience manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.46 in 2024. Return On Capital Employed is likely to drop to -1.07 in 2024. At this time, Aytu BioScience's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 124 M in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 4.3 M in 2024.Similar Executives
| Found 2 records | CFO Age | ||
| Ryan CPA | Lifecore Biomedical | 47 | |
| John Morberg | Lifecore Biomedical | 60 | |
Management Performance
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.0106 |
Aytu BioScience Leadership Team
Elected by the shareholders, the Aytu BioScience's board of directors comprises two types of representatives: Aytu BioScience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aytu. The board's role is to monitor Aytu BioScience's management team and ensure that shareholders' interests are well served. Aytu BioScience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aytu BioScience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joshua Disbrow, CEO, Director | ||
| Russ McMahen, Senior Development | ||
| Mark CPA, Secretary CFO | ||
| Christopher Brooke, Chief Officer | ||
| Margaret Cabano, Vice Operations | ||
| Topher Brooke, Chief Officer | ||
| Greg Pyszczymuka, Chief Officer | ||
| Ryan CPA, Executive Optimization | ||
| Victoria Cordova, Vice Culture | ||
| Jarrett Disbrow, COO, Director |
Aytu Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aytu BioScience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.0106 | ||||
| Profit Margin | (0.20) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 6.41 M | ||||
| Shares Outstanding | 6.15 M | ||||
| Shares Owned By Insiders | 2.43 % | ||||
| Shares Owned By Institutions | 34.04 % | ||||
| Number Of Shares Shorted | 120.8 K | ||||
| Price To Earning | (0.77) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.